Veterinary Medicine

July 18, 2024
Published by Meranda Parascandola at July 18, 2024

How CMC Drug Development Differs within Veterinary Medicine

The costs of developing a new medication can amount to over $1 billion, depending on the complexity of the drug and expenses associated with unsuccessful studies. With these costs in mind, an optimized regulatory process is required to ensure that the procedures behind drug development are secure, safety-oriented, and reliable. […]
Do you like it?
Read more
July 26, 2024
Published by Meranda Parascandola at July 26, 2024

Understanding Global Harmonization of Regulatory CMC for Animal Health

Animal health depends upon veterinary medicine. Developing new medications not only safeguards animals from various diseases and conditions, but also helps prevent the transmission of zoonotic illnesses to humans. Central to this development is regulatory CMC (Chemistry, Manufacturing, and Controls), which focuses on the composition, manufacturing practices, and quality of […]
Do you like it?
Read more
July 26, 2024
Published by Meranda Parascandola at July 26, 2024

DSI to Attend Animal Health Corridor Summit in Kansas City, MO on August 26-27th

Date: July 26, 2024 Location: Kansas City, MO DSI, a renowned pharmaceutical and animal health industry leader, is thrilled to announce its participation in the upcoming Animal Health Corridor Summit on August 26-27, 2024. This summit is a pivotal event for industry leaders, offering a platform for innovation, collaboration, and […]
Do you like it?
Read more
May 2, 2025
Published by Meranda Parascandola at May 2, 2025

FDA CVM vs. USDA CVB: Understanding the Differences in Veterinary Drug and Biologic Approvals 

Introduction  Navigating the regulatory landscape for veterinary pharmaceuticals and biologics can be complex. The U.S. Food and Drug Administration’s Center for Veterinary Medicine (FDA CVM) and the U.S. Department of Agriculture’s Center for Veterinary Biologics (USDA CVB) oversee different aspects of veterinary product approvals. FDA CVM regulates veterinary drugs under […]
Do you like it?
Read more
May 6, 2025
Published by Meranda Parascandola at May 6, 2025

Veterinary GMP Audits: Ensuring Compliance for FDA and USDA Regulations 

Good Manufacturing Practice (GMP) audits play a critical role in ensuring the safety, quality, and efficacy of veterinary pharmaceuticals and biologics. These audits assess compliance with regulatory requirements set forth by agencies such as the FDA’s Center for Veterinary Medicine (CVM) and the USDA’s Center for Veterinary Biologics (CVB). Non-compliance […]
Do you like it?
Read more
May 6, 2025
Published by Meranda Parascandola at May 6, 2025

Trends in Veterinary Drug Development: Addressing the Challenges of Companion Animal Medicines 

The veterinary pharmaceutical industry is at a crossroads as shifting consumer behaviors, economic pressures, and evolving market demands shape the future of companion animal medicines. While the global animal health market continues to grow, stagnation in the small animal sector and a decline in canine wellness visits have presented significant […]
Do you like it?
Read more
1234